Also trades as: RVV.CN (CNQ) · $vol 0M
RVVTF OTC
Revive Therapeutics Ltd.
1W: +26.1%
1M: +15.4%
3M: -2.3%
YTD: +128.3%
1Y: +97.2%
3Y: -38.2%
5Y: -94.5%
$0.02
+0.00 (+16.67%)
Weekly Expected Move ±21.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$2M
+49.9% ▲
Net Income
-$11M
-96.0% ▼
EPS (Diluted)
$-0.03
-102.7% ▼
EBITDA
-$11M
-234.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $775 | $578 | $434 | $0 | $0 |
| Gross Profit | -$775 | -$578 | -$434 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $7M | $15M | $4M | $1M | $145K |
| SG&A Expenses | $12M | $3M | $2M | $2M | $1M |
| Operating Expenses | $19M | $18M | $6M | $3M | $2M |
| Operating Income | -$19M | -$18M | -$6M | -$3M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $79K | $63K | $44K | $0 | $632 |
| Income Before Tax | -$20M | -$18M | -$6M | -$6M | -$11M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$20M | -$18M | -$6M | -$6M | -$11M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.08 | $-0.06 | $-0.02 | $-0.01 | $-0.03 |
| EBITDA | -$19M | -$18M | -$6M | -$3M | -$11M |
| Shares Outstanding | 267M | 320M | 339M | 380M | 420M |